Monday, October 04, 2021 11:37:25 AM
Recent MRK News
- Futures Pointing To Another Lackluster Session On Wall Street • IH Market News • 07/30/2024 01:23:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 10:41:50 AM
- Merck Announces Second-Quarter 2024 Financial Results • Business Wire • 07/30/2024 10:30:00 AM
- U.S. Futures Climb Before Fed Meeting; Oil Prices Drop on China Demand Worries • IH Market News • 07/30/2024 10:06:14 AM
- F5 Shares Rise 15%; Diageo Falls 10% on Annual Sales Decline; BP Boosts Dividend and Buyback Program • IH Market News • 07/30/2024 10:03:59 AM
- U.S. Stocks Finish Choppy Trading Session Little Changed • IH Market News • 07/29/2024 08:44:00 PM
- Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma • Business Wire • 07/26/2024 10:50:00 AM
- Merck Announces Fourth-Quarter 2024 Dividend • Business Wire • 07/23/2024 04:52:00 PM
- Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus Preventative Monoclonal Antibody for Infants • Business Wire • 07/23/2024 10:45:00 AM
- Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024 • Business Wire • 07/16/2024 10:45:00 AM
- Merck Completes Acquisition of EyeBio • Business Wire • 07/12/2024 10:45:00 AM
- Merck Animal Health Completes Acquisition of Elanco’s Aqua Business • Business Wire • 07/09/2024 12:30:00 PM
- Elanco Completes Sale of Aqua Business • PR Newswire (US) • 07/09/2024 12:28:00 PM
- Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer • Business Wire • 07/01/2024 12:15:00 PM
- Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30 • Business Wire • 07/01/2024 10:45:00 AM
- Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH) • Business Wire • 06/28/2024 10:53:00 AM
- CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults • Business Wire • 06/28/2024 12:18:00 AM
- Interactive Brokers Loses $48 Million on NYSE, Amazon Achieves Historic Market Value, and More News • IH Market News • 06/27/2024 11:13:41 AM
- Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer • Business Wire • 06/26/2024 11:45:00 PM
- USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza • Business Wire • 06/25/2024 08:05:00 PM
- Fisker Files for Bankruptcy, Chegg Stocks Rise on 23% Workforce Reduction, and More • IH Market News • 06/18/2024 11:02:13 AM
- U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults • Business Wire • 06/17/2024 09:29:00 PM
- FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma • Business Wire • 06/17/2024 09:15:00 PM
- Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 06/05/2024 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 07:02:25 PM
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM